{"filing":{"accession_number":"0001929561-26-000033","cik":"0001929561","ticker":"RXO","company_name":"RXO, Inc.","form":"8-K","filing_date":"2026-08-06","report_date":"2026-08-06","primary_document":"rxo-20260806.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1929561/000192956126000033/rxo-20260806.htm"},"events":[{"id":26012,"run_id":23622,"accession_number":"0001929561-26-000033","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.97,"summary":"RXO issued a press release on August 6, 2026 announcing its results of operations for the fiscal quarter ended June 30, 2026, disclosing revenue of $1.774 billion, a GAAP net loss of $9 million, adjusted net income of $10 million, and adjusted EBITDA of $40 million, along with third-quarter 2026 guidance.","company_name":"RXO, Inc.","ticker":"RXO","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":[{"id":26987,"accession_number":"0001929561-26-000033","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"RXO issued a press release on August 6, 2026 announcing its results of operations for the fiscal quarter ended June 30, 2026, disclosing revenue of $1.774 billion, a GAAP net loss of $9 million, adjusted net income of $10 million, and adjusted EBITDA of $40 million. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for quarterly earnings disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:55:20.016264+00:00","company_name":"","ticker":null,"filing_date":""},{"id":26988,"accession_number":"0001929561-26-000033","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"RXO disclosed its second-quarter 2026 financial results on August 6, 2026, including revenue of $1.774 billion, net loss of $9 million, and adjusted EBITDA of $40 million, along with third-quarter 2026 guidance. The press release (Exhibit 99.1) presents comprehensive quarterly results with segment performance, forward-looking guidance, and management commentary, which is the hallmark of an earnings release disclosure under Item 2.02 (also furnished under Item 7.01).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:55:20.016264+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26987,"accession_number":"0001929561-26-000033","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"RXO issued a press release on August 6, 2026 announcing its results of operations for the fiscal quarter ended June 30, 2026, disclosing revenue of $1.774 billion, a GAAP net loss of $9 million, adjusted net income of $10 million, and adjusted EBITDA of $40 million. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for quarterly earnings disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:55:20.016264+00:00","company_name":"RXO, Inc.","ticker":"RXO","filing_date":"2026-08-06"},{"id":26988,"accession_number":"0001929561-26-000033","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"RXO disclosed its second-quarter 2026 financial results on August 6, 2026, including revenue of $1.774 billion, net loss of $9 million, and adjusted EBITDA of $40 million, along with third-quarter 2026 guidance. The press release (Exhibit 99.1) presents comprehensive quarterly results with segment performance, forward-looking guidance, and management commentary, which is the hallmark of an earnings release disclosure under Item 2.02 (also furnished under Item 7.01).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:55:20.016264+00:00","company_name":"RXO, Inc.","ticker":"RXO","filing_date":"2026-08-06"}]}